CVS Health Updates EPS Guidance and Operational Plans
CVS Health revises full-year EPS guidance to $6.40-$6.55 and plans significant operational improvements to drive future growth.
- Latest
- Trending
CVS Health revises full-year EPS guidance to $6.40-$6.55 and plans significant operational improvements to drive future growth.
Walgreens Boots Alliance explores the $4 billion sale of its specialty pharmacy business, Shields Health Solutions, as part of its ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.